pharmaunternehmen in Retschwil

Explore Janssen’s innovative medical research and development practices, and see how Janssen is dedicated to the well-being of patients around the world.

Biogen develops, manufactures and markets innovative therapies for patients living with serious neurological, autoimmune and rare diseases.

Hans Peter Hasler. Experienced Pharma-and Biotech-Executive. From 2001 on with Biogen Idec. Most recently, until mid-2009, Chief Operating Officer of Biogen Idec Inc., Cambridge/USA. Various Exec…